Autopsy report · NCT05140135
Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy
Cause of deathFunding or business
“The funds used to originally support the study were withdrawn.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Conditions
- Schizophrenia; Schizoaffective Disorder
- Interventions
- Recovery Oriented Cognitive Therapy (CT-R); Treatment as Usual
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
“Study funding was withdrawn.” - Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study
“Funding for study was withdrawn” - Racial Disparity in Endometrial Cancer
“Funding and logistical difficuties resulted in the withdrawl of the study.” - Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
“The study withdrawn due to lack financial support” - NRX-1074 in Early Course Schizophrenia
“The study was withdrawn by the sponsor.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.